IL6 and breast cancer: Building upon the mechanistic insights from Yang et al.’s investigation, their research demonstrated that IL-6 may serve as a pivotal molecular mediator through which polychlorinated biphenyl (PCB) exposure disrupts breast cancer pathogenesis [42].